Abbott Laboratories (ABT)
NYSE: ABT · Real-Time Price · USD
116.54
-0.47 (-0.40%)
Oct 24, 2024, 4:00 PM EDT - Market closed
Abbott Laboratories Stock Forecast
Stock Price Forecast
The 16 analysts with 12-month price forecasts for Abbott Laboratories stock have an average target of 128.88, with a low estimate of 117 and a high estimate of 146. The average target predicts an increase of 10.59% from the current stock price of 116.54.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for ABT stock from 16 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 |
---|---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 4 | 3 | 4 |
Buy | 5 | 5 | 5 | 5 | 6 | 8 |
Hold | 3 | 3 | 1 | 1 | 2 | 4 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 11 | 11 | 9 | 10 | 11 | 16 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Bernstein | Bernstein | Buy Maintains $133 → $138 | Buy | Maintains | $133 → $138 | +18.41% | Oct 17, 2024 |
UBS | UBS | Strong Buy Maintains $143 → $146 | Strong Buy | Maintains | $143 → $146 | +25.28% | Oct 17, 2024 |
Jefferies | Jefferies | Hold Maintains $120 → $125 | Hold | Maintains | $120 → $125 | +7.26% | Oct 17, 2024 |
Mizuho | Mizuho | Hold Maintains $115 → $130 | Hold | Maintains | $115 → $130 | +11.55% | Oct 17, 2024 |
Piper Sandler | Piper Sandler | Buy Maintains $131 → $133 | Buy | Maintains | $131 → $133 | +14.12% | Oct 17, 2024 |
Financial Forecast
Revenue This Year
42.15B
from 40.11B
Increased by 5.09%
Revenue Next Year
45.25B
from 42.15B
Increased by 7.35%
EPS This Year
4.71
from 3.26
Increased by 44.39%
EPS Next Year
5.19
from 4.71
Increased by 10.36%
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 44.0B | 47.7B | 51.7B | ||
Avg | 42.2B | 45.3B | 48.7B | ||
Low | 40.7B | 43.5B | 46.5B |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 9.7% | 13.2% | 14.1% | ||
Avg | 5.1% | 7.4% | 7.5% | ||
Low | 1.5% | 3.1% | 2.8% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 4.96 | 5.59 | 6.28 | ||
Avg | 4.71 | 5.19 | 5.68 | ||
Low | 4.54 | 4.96 | 4.51 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 52.0% | 18.7% | 20.9% | ||
Avg | 44.4% | 10.4% | 9.3% | ||
Low | 39.2% | 5.3% | -13.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.